Pharmacological properties of serotonin receptor subtypes mediating contraction of bovine inferior alveolar arteries

Archives of Oral Biology

Volumn 49, Issue 3, 2004, Pages 223-232

  O'Donohue, H A ^a   Abel, P W ^a   Bockman, C S ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT receptor subtypes; 5 Hydroxytryptamine; Bovine; Ibuprofen; Inferior alveolar artery; Prostacyclin; Serotonin

Indexed keywords

BOVINAE;

EID: 0742305644     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2003.09.003     Document Type: Article

References (36)

1. Kim S., Trowbridge H.O., Dorscher-Kim J.E. The influence of 5-hydroxytryptamine (serotonin) on blood flow in the dog pulp. J. Dent. Res. 65:1986;682-685.
2. Liu M., Kim S., Park D.S., Markowitz K., Bilotto G., Dorscher-Kim J. Comparison of the effects of intra-arterial and locally applied vasoactive agents on pulpal blood flow in dog canine teeth determined by laser Doppler velocimetry. Arch. Oral. Biol. 35:1990;405-410.
3. Yu C.Y., Boyd N.M., Cringle S.J., Su E.N., Alder V.A., Yu D.Y. Agonist-induced vasoactive responses in isolated perfused porcine dental pulpal arterioles. Arch. Oral. Biol. 47:2002;99-107.
4. Yu C.Y., Boyd N.M., Cringle S.J., Su E.N., Alder V.A., Yu D.Y. An in vivo and in vitro comparison of the effects of vasoactive mediators on pulpal blood vessels in rat incisors. Arch. Oral. Biol. 47:2002;723-732.
5. Castelli W.A., Nasjleti C.E., Diaz-Perez R. Interruption of the arterial inferior alveolar flow and its effects on mandibular collateral circulation and dental tissues. J. Dent. Res. 54:1975;708-715.
6. Dufour G., Jonck L.M. Effect on the mandible of ligation of the external carotid artery and destruction of the inferior alveolar artery. J. Can. Dent. Assoc. 46:1980;307-311.
7. Vanhoutte P.M. Vascular effects of serotonin and ischemia. J. Cardiovasc. Pharmacol. 16:1990;S15-S19.
8. Martin G.R. Vascular receptors for 5-hydroxytryptamine: distribution, function and classification. Pharmacol. Ther. 62:1994;283-324.
9. Hoyer D., Clarke D.E., Fozard J.R.et al. International Union of Pharmacology. VII. Classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev. 46:1994;157-203.
10. Hoyer D., Martin G. 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology. 36:1997;419-428.
11. Junod A.F., Ody C. Amine uptake and metabolism by endothelium of pig pulmonary artery and aorta. Am. J. Physiol. 232:1977;C88-C94.
12. Purdy R.E., Milburn M.R. Evidence against serotonin-induced endothelium-dependent relaxation in bovine coronary artery. J. Pharmacol. Exp. Ther. 259:1991;1316-1322.
13. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14:1959;48-58.
14. Kenakin TP. Drug antagonism in pharmacologic analysis of drug-receptor interaction. New York: Raven; 1987. p. 205-44.
15. Bockman C.S., Jeffries W.B., Abel P.W. Binding and functional characterization of alpha-2 adrenergic receptor subtypes on pig vascular endothelium. J. Pharmacol. Exp. Ther. 267:1993;1126-1133.
16. Bockman C.S., Gonzalez-Cabrera I., Abel P.W. Alpha-2 adrenoceptor subtype causing nitric oxide-mediated vascular relaxation in rats. J. Pharmacol. Exp. Ther. 278:1996;1235-1243.
17. 2 and affinity constants for pharmacological competitive antagonists be estimated? J. Pharm. Pharmacol. 30:1978;312-313.
18. Motulsky H.J., Ransnas L.A. Fitting curves to data using non-linear regression: a practical and nonmathematical review. FASEB J. 1:1987;365-374.
19. ®. San Diego: GraphPad Software Inc.; 1999. p. 157-242.
20. Cohen L. Further studies into the vascular architecture of the mandible. J. Dent. Res. 39:1960;936-945.
21. Vanhoutte P.M. 5-Hydroxytryptamine and vascular disease. Federation Proc. 42:1983;233-237.
22. 1A receptors. Eur. J. Pharmacol. 237:1993;283-291.
23. 1D receptor subtypes mediating cerebral vasoconstriction. Cephalalgia. 15:1995;99.
24. 1B/1D receptor antagonist GR55562. Pharmacol. Toxicol. 86:2000;287-290.
25. Verheggen R., Freudenthaler S., Meyer-Dulheuer F., Kaumann A.J. Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs. Br. J. Pharmacol. 117:1996;283-289.
26. Bonhaus D.W., Weinhardt K.K., Taylor M.et al. RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology. 36:1996;621-629.
27. 7 receptors: current knowledge and future prospects. Trends Pharmacol. Sci. 21:2000;70-77.
28. 2B receptors of endothelium-dependent relaxation in rat jugular vein. Br. J. Pharmacol. 114:1995;400-404.
29. Glusa E., Pertz H.H. Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B) receptors. Br. J. Pharmacol. 130:2000;692-698.
30. 7 receptor mediating smooth muscle relaxation in canine cerebral arteries. Br. J. Pharmacol. 127:1999;609-616.
31. Bradley J.C. A radiological investigation into the age changes of the inferior dental artery. Br. J. Oral. Surg. 13:1975;82-90.
32. Obradovic O., Bogdanovic D., Cvetkovic D., Pesic V., Petrovic V., Dozic S. Atherosclerotic changes of the inferior dental artery correlated with those of the carotid bifurcation and the abdominal artery. Bull. Group Int. Rech. Sci. Stomatol. Odontol. 32:1989;105-110.
33. Pogrel M.A., Dodson T., Tom W. Arteriographic assessment of patency of the inferior alveolar artery and its relevance to alveolar atrophy. J. Oral. Maxillofac. Surg. 45:1987;767-770.
34. Semba I., Funakoshi K., Kitano M. Histomorphometric analysis of age changes in the human inferior alveolar artery. Arch. Oral. Biol. 46:2001;13-21.
35. Heistad D.D., Armstrong M.L., Baumbach G.L., Faraci F.M. Sick vessel syndrome. Recovery of atherosclerotic and hypertensive vessels. Hypertension. 26:1995;509-513.
36. 2 from isolated rat dental pulp. Eur. J. Pharmacol. 136:1987;433-436.